此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Warm Homes for Elder New Zealanders (WHEZ)

2015年6月15日 更新者:Philippa Howden-Chapman、University of Otago

Warm Homes for Elder New Zealanders: a Community Trial of People With COPD

Aim

The purpose of this study is to evaluate whether fuel subsidies reduce exacerbations of COPD among people aged over 55, and therefore whether providing such subsidies is a cost-beneficial policy initiative.

The Warm Homes for Elder New Zealanders Study enrolled community-dwelling people aged over 55 with moderate or worse COPD. Prior to the study commencing the houses were insulated (if feasible, & the house-owner agreed). Data were collected on the health and energy use of the participants.

The households randomly assigned to the "early" intervention group had a subsidy to their power account their first winter in the study. The subsidy was the intervention and was designed to enable the participants, if they chose to do so, to keep their house warmer during the winter.

研究概览

详细说明

Warm Homes for Elder New Zealanders (WHEZ)

Background Although there has been considerable recent work on the prevention, management and causes of Chronic Obstructive Pulmonary Disease (COPD), the contribution of housing has not been well researched. This is despite the socio-economic patterning of COPD (Maori women have the highest rate of COPD that has been recorded for any group of women), and the relationship between socio-economic deprivation and housing conditions.

It is likely that improved heating would reduce exacerbations of COPD as:

  • COPD patients with the most advanced disease tend to be older people who often live on a fixed income and may be unable to afford adequate heating
  • There is a high excess of winter hospitalisations in COPD patients indicating COPD exacerbations may be triggered by cold conditions.
  • About one third of exacerbations of COPD are triggered by respiratory infections.
  • The Housing, Insulation and Health Study demonstrated a reduction in self-reported respiratory disease after houses were insulated. Therefore improving the heating in households with a COPD patient may reduce respiratory infections and this in turn would reduce the number and severity of exacerbations.

The percentage of people over 65 in New Zealand will increase from 12% to 22% over the next 25 years. Therefore it will become increasingly important to find cost-effective ways of reducing the morbidity of the older age group. As COPD is a significant cause of morbidity amongst older people, this study investigates a potentially cost effective intervention to reduce both the likelihood of expensive hospital stays and improve the quality of life for older people.

Aim To evaluate whether fuel subsidies reduce exacerbations of COPD among people aged over 55, and therefore whether providing such subsidies is a cost-beneficial policy initiative.

Potential Benefits The potential benefits of the study include reducing the burden of disease. The patients and their caregivers may experience improved quality of life. Hospitals may experience fewer patients requiring treatment during the winter. A cost-benefit analysis will quantify the benefits.

研究类型

介入性

注册 (实际的)

522

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Christchurch、新西兰
        • Christchurch
      • Wanganui、新西兰
        • Wanganui / Manawatu
      • Wellington、新西兰
        • Wellington / Hutt/ Porirua

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

55年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Post Bronchodilator FEV1/FVC ratio < Lower Limit of Normal (NHanesIII)
  • Post Bronchodilator FEV1 < 80% of the predicted FEV1 (NHanesIII)

OR - In the last three years either went to hospital for their COPD or took antibiotics/steriods for their COPD

Exclusion Criteria:

  • Not planning to stay in the same dwelling until the end of the study
  • Does not want to take part in research
  • Unwilling to answer inclusion questionnaire
  • Unable to communicate effectively

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Voucher
Receive the intervention ("Energy Voucher") the first winter enrolled in the study. The intervention is a electricity voucher and a short pamphlet describing how to work out how much heat the voucher can buy.
Receive the intervention the first winter enrolled in the study. The intervention is a electricity voucher and a short pamphlet describing how to work out how much heat the voucher can buy.
其他:Control
Receive the intervention the second winter enrolled in the study (thus "No intervention : control arm"). The intervention is a electricity voucher and a short pamphlet describing how to work out how much heat the voucher can buy.
Do not receive the money or pamphlet in the initial study year

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Moderate or severe exacerbations of COPD during winter for which hospitalisation, systemic corticosteroids and/or antibiotics are required to treat the exacerbation
大体时间:Four months
Four months

次要结果测量

结果测量
大体时间
Severe exacerbations of COPD during winter for which hospitalisation is required to treat the exacerbation
大体时间:Four months
Four months
Moderate exacerbations of COPD during winter; which will be defined as requiring treatment with systemic corticosteroids and/or antibiotics
大体时间:Four months
Four months
All-cause hospitalisation during winter
大体时间:Four months
Four months
Temperature in the living and bedrooms during winter
大体时间:Four months
Four months
Electricity usage during winter
大体时间:Four months
Four months
Costs to health care system of index participant during winter
大体时间:Four months
Four months
Self-reported quality of life for index participant during winter
大体时间:Four months
Four months
Respiratory health of other people living in household during winter
大体时间:Four months
Four months
Any changes in index participant baseline lung function
大体时间:course of study ( up to 18 months)
course of study ( up to 18 months)
Study withdrawals due to death or greater dependency
大体时间:course of study (up to 18 months)
course of study (up to 18 months)
Support person burden
大体时间:course of study (up to 18 months)
course of study (up to 18 months)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Philippa L Howden-Chapman, PhD、University of Otago

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2009年4月1日

初级完成 (实际的)

2013年2月1日

研究完成 (实际的)

2013年2月1日

研究注册日期

首次提交

2011年8月2日

首先提交符合 QC 标准的

2012年6月20日

首次发布 (估计)

2012年6月25日

研究记录更新

最后更新发布 (估计)

2015年6月17日

上次提交的符合 QC 标准的更新

2015年6月15日

最后验证

2015年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • HRC08/072AR

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅